Kinetic constants and sample-to-sample variation in the rate of metabolism of two or more substrates for human liver microsomal CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP3A4

被引：0
|
作者：
Woodworth, Zell [1 ]
Dwyer, L. Anne [1 ]
Collins, Lisa [1 ]
Graves, Terry [1 ]
Helmstetter, Stephanie [1 ]
Ogilvie, Brian [1 ]
Otwell, Clayton [1 ]
Pope, Chad [1 ]
Ramsey, Tiffin [1 ]
Yerino, Phyllis [1 ]
Parkinson, Andrew [1 ]
机构：
[1] XenoTech LLC, Lenexa, KS USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
107
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] REVERSIBLE AND TIME-DEPENDENT INHIBITION (TDI) OF CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 AND CYP3A4 IN HUMAN HEPATOCYTE SUSPENSIONS BY MODEL INHIBITORS
    Zhang, J. George
    Thuy Ho
    Patel, Reena
    Trisdale, Sarah K.
    Creegan, Tim
    Stresser, David M.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S57 - S58
  • [2] Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro
    Pan, Yan
    Tiong, Kai Hung
    Abd-Rashid, Badrul Amini
    Ismail, Zakiah
    Ismail, Rusli
    Mak, Joon Wah
    Ong, Chin Eng
    JOURNAL OF NATURAL MEDICINES, 2014, 68 (02) : 402 - 406
  • [3] Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro
    Yan Pan
    Kai Hung Tiong
    Badrul Amini Abd-Rashid
    Zakiah Ismail
    Rusli Ismail
    Joon Wah Mak
    Chin Eng Ong
    Journal of Natural Medicines, 2014, 68 : 402 - 406
  • [4] Effect of fifteen CYP3A4 in vitro inducers on the induction of CYP2B6, CYP2C8, CYP2C9, CYP2C19 and CYP3A5 in plated human hepatocytes: a trend analysis
    Zhang, J. George
    Patel, Reena
    Clark, Robert J.
    Ho, Thuy
    Trisdale, Sarah K.
    Stresser, David M.
    DRUG METABOLISM REVIEWS, 2016, 48 : 84 - 84
  • [5] The effects of buffer composition on the catalytic activities of human CYP1A2, CYP2C9, CYP2D6, and CYP3A4
    Gillespie, JS
    Binkley, SN
    Ring, BJ
    Wrighton, SA
    FASEB JOURNAL, 1998, 12 (04): : A144 - A144
  • [6] COMPARISON OF THE EFFECT OF CHRONIC KIDNEY DISEASE (CKD) ON PHARMACOKINETICS OF CYP1A2, CYP2C8, CYP2C9 AND CYP2C19 SUBSTRATES
    Tan, M-L
    Yoshida, K.
    Zhao, P.
    Zhang, L.
    Galetin, A.
    Huang, S-M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S10 - S11
  • [7] SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS
    De Andres, F.
    Paulmichl, M.
    Llerena, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S61 - S61
  • [8] Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans
    Thorn, Helena Anna
    Lundahl, Anna
    Schrickx, Johannes Antonius
    Dickinson, Paul Alfred
    Lennernas, Hans
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (03) : 89 - 98
  • [9] Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes
    Hijazi, Y
    Boulieu, R
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 853 - 858
  • [10] Global variation in CYP2C8–CYP2C9 functional haplotypes
    William C Speed
    Soonmo Peter Kang
    David P Tuck
    Lyndsay N Harris
    Kenneth K Kidd
    The Pharmacogenomics Journal, 2009, 9 : 283 - 290
12345